FITY.US Fifty 1 Labs, Inc.
- Market cap
- USD 119K
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Jun 2026.
Is FITY.US undervalued?
Graham numberThe Graham number of Fifty 1 Labs, Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Fifty 1 Labs, Inc. fundamental analysis
No fundamental analysis for Fifty 1 Labs, Inc. yet.
Fifty 1 Labs, Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Fifty 1 Labs, Inc.
Fifty 1 Labs, Inc., a biotechnology and life sciences company, which focuses on peptide products, peptide discovery, AI-enabled research, and clinical development in the United States. The company provides sports supplements; peptides; telepath products, as well as health and wellness solutions. It offers supplements such as, pre-workout formulas, BCAAS, ION+ electrolyte formula, turmeric gummies, and ashwagandha gummies. The company was formerly known as Consumer Automotive…
Full company profileFifty 1 Labs, Inc. financial statements
Fifty 1 Labs, Inc. annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | - | 131K | 22.3K | 16.5K | 73.9K | 18.0K | 92.1K | 72.00 | - | 47.00 |
| Gross Profit | - | 50.0K | 21.5K | 2.10K | 33.9K | 10.4K | 47.0K | 13.00 | - | - |
| Operating Income | -107M | -102M | -148K | -57.8K | -63.1K | -65.3K | -527K | -1.25K | -359K | -168K |
| EBITDA | -107M | -19.2K | -148K | -57.8K | -63.1K | 18.0K | 92.1K | -1.25K | -359K | -168K |
| Net Income | -1.08K | -17.5K | -112K | -34.8K | -43.1K | 14.7K | -507K | -1.25K | -359K | -246K |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Balance Sheet | ||||||||||
| Total Assets | - | 128K | 62.2K | 110K | 67.0K | 26.0K | 26.0K | 26.6K | 6.54K | 6.37K |
| Total Liabilities | - | 102K | 122K | 110K | 164K | 188K | 186K | 146K | 211K | 802K |
| Shareholders' Equity | - | 134K | 97.2K | 147.00 | -96.7K | -162K | -160K | -120K | -204K | -796K |
| Cash & Short-term Investments | - | 12.7K | 1.36K | 39.8K | 16.9K | - | 0.00 | -17.00 | 4.97K | 4.80K |
| Total Debt | - | 525.00 | 525.00 | 110K | 164K | 109K | 93.1K | 65.0K | 211K | 168K |
| Cash Flow | ||||||||||
| Operating Cash Flow | - | -18.0K | -41.3K | -34.8K | -43.1K | -98.5K | 17.5K | -1.84K | -496K | -74.6K |
| Capital Expenditure | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.00 | 3.00 | 0.00 |
| Free Cash Flow | - | -18.0K | -41.3K | -34.8K | -43.1K | -98.5K | 17.5K | -1.84K | -496K | -74.6K |
| Ratios | ||||||||||
| ROE | - | -13.0% | -115.1% | -23,700.7% | - | - | - | - | - | - |
| ROA | - | -13.6% | -179.9% | -31.7% | -64.4% | 56.4% | -1,948.2% | -4.7% | -5,491.4% | -3,859.8% |
| Net Profit Margin | - | -13.3% | -501.4% | -211.2% | -58.3% | 81.6% | -550.4% | -1,733.3% | - | -523,204.3% |
| Debt to Equity | - | 0.00x | 0.01x | 747.68x | - | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Fifty 1 Labs, Inc. dividends
Fifty 1 Labs, Inc. has not paid dividends in the last 10 fiscal years.
Who owns Fifty 1 Labs, Inc.
Ownership data of Fifty 1 Labs, Inc. is not available yet.
Fifty 1 Labs, Inc. company profile
- Company name
- Fifty 1 Labs, Inc.
- Ticker
- FITY.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 2
- Fiscal year end
- June
- Address
- 1505 W 2nd Ave, Vancouver, BC, Canada, V6J 1H2
- Phone
- 877 505 5006
- Website
- fifty1labs.com
About Fifty 1 Labs, Inc.
Fifty 1 Labs, Inc., a biotechnology and life sciences company, which focuses on peptide products, peptide discovery, AI-enabled research, and clinical development in the United States. The company provides sports supplements; peptides; telepath products, as well as health and wellness solutions. It offers supplements such as, pre-workout formulas, BCAAS, ION+ electrolyte formula, turmeric gummies, and ashwagandha gummies. The company was formerly known as Consumer Automotive Finance, Inc. and changed its name to Fifty 1 Labs, Inc. in March 2025. Fifty 1 Labs, Inc. was incorporated in 1998 and is based in Vancouver, Canada.
Fifty 1 Labs, Inc. management
6- Dr. Joel Gagnier M.Sc., Ph.D.CEO & Chief Science Officer
- Mr. Brandon SpikesPresident & Director
- Dr. Alind Gupta Ph.D.Chief Technology Officer
- Dr. Nima Sakian M.D.Chief Medical Officer
- Mr. Martin Mills M.Sc.Chief Growth Officer
- Mr. Richard Steven Robins B.A., M.B.A.Chief Business Development Advisor · born 1973